About the Project

Focal Technology Area (FTA) on Nanomedicines for Personalized Theranostics is a consortium of 11 research laboratories at several universities that will develop nanometer-sized drug delivery systems for theranostics (therapy and diagnostics) of angiogenesis-dependent diseases such as cancer, inflammation and cardiovascular diseases in a personalized manner. The Israel National Nanotechnology Initiative (INNI) is responsible for the project, which is led by Prof. Dan Peer, of the Department of Cell Research and Immunology at Tel Aviv University.

Save the date:
New Horizons in Nanomedicine
June 24-25, 2015, Tel Aviv University

The 9 th Annual Meeting of the
Israeli Chapter of the
Controlled Release Society

September 9-11, 2014
Hacienda Forestview Hotel
Maalot Tarshiha, Israel
ICRS site